Gere Sunder–Plassmann

1. Nature and Prevalence of Pain in Fabry Disease and Its Response to Enzyme Replacement Therapy—A Retrospective Analysis From the Fabry Outcome Survey
   2007/06/15 by B. Hoffmann, Michael Beck, Gere Sunder–Plassmann +3 · 4 citations
   Medicine · #Lysosomal Storage Disorders Research #Glycogen Storage Diseases and Myoclonus #Biomedical Research and Pathophysiology #Fabry disease #Enzyme replacement therapy #Medicine #Retrospective cohort study #Cohort #Disease #Internal medicine #Pediatrics
2. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
   2023/02/01 by Jesse J Swen, Jesse J. Swen, Cathelijne H. van der Wouden +277 · 6 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Genomics and Rare Diseases #Pharmaceutical studies and practices #Pharmacogenetics and Drug Metabolism
3. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
   2016/11/10 by Derralynn Hughes, Kathy Nicholls, Suma P. Shankar +35 · 3 citations
   Medicine · #Lysosomal Storage Disorders Research #Biomedical Research and Pathophysiology #Glycogen Storage Diseases and Myoclonus #Fabry disease #Enzyme replacement therapy #Medicine #Internal medicine #Bioinformatics #Pharmacology #Disease #Biology